To save lives, the FDA must change how it evaluates rare disease treatments
For some conditions, few approved treatments exist. Without accelerated approval, the FDA is failing patients
Stay updated with breaking news from Accelerated Approval Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For some conditions, few approved treatments exist. Without accelerated approval, the FDA is failing patients
Valneva said it hopes to commercialize the vaccine in the U.S. early next year.
FDA panel urges Acrotech Biopharma to accelerate research into two blood cancer drugs approved via the FDA's accelerated approval pathway.
The Oregon Democrat lost his bid for reelection last year and is now a principal at Williams and Jensen, which represents a number of pharmaceutical clients.
Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.